Skip to content

Clinical Research on Omics in Patients with Different Types of Cardiomyopathy

Clinical Research on Omics in Patients with Different Types of Cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115621
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-09-10
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial cardiomyopathy

Interventions

Supraventricular tachycardia group:None

Sponsors

Afiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with cardiomyopathy through clinical evaluation

Exclusion criteria

Exclusion criteria: 1. Missing clinical electronic medical records, including medical history, laboratory tests, imaging examinations, etc. 2. Identify cardiomyopathy caused by secondary factors, such as autoimmune cardiomyopathy, cardiomyopathy secondary to metabolic endocrine and nutritional diseases, or cardiomyopathy complicated by diseases of other organs; 3. Concurrent severe infection.

Design outcomes

Primary

MeasureTime frame
Mononuclear lymphocytes transcriptomics;

Secondary

MeasureTime frame
Serum metabolomics;

Countries

China

Contacts

Public ContactWang Xiaoyan

Afiliated Hospital of Jiangnan University

9862019082@jiangnan.edu.cn+86 510 8868 2205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026